Teen girls are experiencing record high levels of sadness and violence, according to a new report published Monday by the Centers for Disease Control and Prevention.
Driving the news: According to the report, 57% of teen girls in 2021 reported feeling "persistently sad or hopeless" over the past year, up from 36% in 2011 and the highest rate seen in the last decade.
Medication used to treat opioid use disorder has become cheaper over the last several years, but affordability can still be a problem, depending on a patient's insurance, according to a study published in JAMA Network Open.
Buzz from celebrities and social media influencers around the off-label use of diabetes drugs for weight loss is prompting a spike in prescriptions and concerns about cost and possible shortages.
The big picture: More than 5 million prescriptions were written for Novo Nordisk’s Ozempic, Wegovy or Rybelsus,or Eli Lilly’s Mounjaro for weight management in 2022, up from about 230,000 in 2019, per Komodo Health.
Employer-sponsored health plans pay significantly more than Medicare for costly physician-administered drugs, threatening access to lifesaving treatments, according to a newly published analysis of claims data and Medicare files.
What they found: Price markups increased between 2016 and 2020 for five of the top 10 drugs that account for the most spending and more than doubled for three: the white blood cell-booster pegfilgrastim and the cancer drugs trastuzumab and rituximab.
